πŸ‡ΊπŸ‡Έ FDA
Patent

US 11180493

SGC stimulators

granted A61PA61P21/00A61P25/00

Quick answer

US patent 11180493 (SGC stimulators) held by Cyclerion Therapeutics, Inc. expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Cyclerion Therapeutics, Inc.
Grant date
Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P21/00, A61P25/00, A61P25/02, A61P25/04